Description
NOBIVAC® INTRA-TRAC®3 has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica. NOBIVAC® INTRA-TRAC®3 PROVIDES PROTECTION AGAINST TRACHEOBRONCHITIS (“CANINE COUGH”). Canine Adenovirus 2, Canine Parainfluenza Virus (modified live viruses), Bordetella Bronchiseptica (avirulent live culture).
Benefits
- Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type
- Offers the superior benefits of intranasal administration
- Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
- Requires only single-nostril administration—low dose of 0.5 mL
- Provides rapid protection beginning as early as 48 hours post-vaccination against B. bronchiseptica14
- Proven 1-year duration of immunity for B. bronchiseptica15
Dosage and Administration
- DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS
Put 1 ml into one nostril, or split dose between both nostrils. For small dogs and puppies, a 0.5 ml dose may be prepared by mixing 0.5 ml diluent with standard, full dose of powder. Annual revaccination is recommended. Requires mixing. Applicator tips are included. Order syringes separately.
CAUTION
1. THIS PRODUCT IS DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence, jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs, monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin, tetracycline, trimethoprim/sulfa, or amoxicillin/clavulanic acid may be indicated. If anaphylactoid reaction occurs, use epinephrine.
2. Post vaccinal reactions consisting of mild canine cough syndrome may occur following use of this vaccine.
3. For animal use only. Store at 2° - 8°C (35° - 46°F). Do not freeze. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant bitches. Inactivate unused contents before disposal. In case of human exposure, contact a physician.
4. This vaccine contains penicillin, streptomycin and nystatin as preservatives.
Other Nobivac Canine products available. Call 1-800-934-9398.
Nobivac Intra-Trac 3 is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a styrofoam cooler with ice packs.
Click here for our Vaccine Shipping Schedule.
by Merck
Nobivac® Intra-Trac®3
Canine Adenovirus Type 2, Parainfluenza, Bordetella Bronchiseptica Vaccine, MODIFIED LIVE VIRUS, AVIRULENT LIVE CULTURE
Nobivac® Intra-Trac®3 vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough. Duration of Immunity (DOI) has been demonstrated to be at least one year for Bordetella bronchiseptica.
Features and benefits
- Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type 2
- Offers the superior benefits of intranasal administration
- Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
- Requires only single-nostril administration—low dose of 0.5 mL
- Provides rapid protection as early as 48 hours post-vaccination1*
- Provides 1-year duration of immunity 2
Indication
- Approved for the vaccination of healthy dogs as an aid in prevention of infectious disease associated with canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica infection
- Recommended for use in healthy dogs 3 weeks of age or older
Administration and Dosage
- DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS
- Flexible dosing – For one 1 mL dose, rehydrate vaccine with 1 mL sterile diluent or for one 0.5 mL dose, rehydrate vaccine with 0.5 mL sterile diluent.
- Annual revaccination with 1 dose is recommended
Bordetella + Adenovirus + Parainfluenza Modified live + avirulent live Bordetella bronchiseptica. For protection against canine adenovirus type 2, parainfluenza and Bordetella bronchiseptica. For dogs 3 weeks of age or older. Give intranasally. Instill 1 ml into one nostril, or split dose between both nostrils. For small dogs and puppies, a 0.5 ml dose may be prepared by mixing 0.5 ml diluent with standard, full dose of powder. Annual revaccination is recommended. Requires mixing. Applicator tips are included. Order syringes separately.
*Based on Bordetella bronchiseptica challenge.
Please Note:
* Don't forget to order needles and syringes.
All Vaccines Now Ship
OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a styrofoam cooler with ice packs on
Monday-Thursdays (on orders placed before 2:00pm Central Time)
Click here for our Vaccine Shipping Schedule.
Other Nobivac Canine products available. Call 1-800-934-9398.